Results 11 to 20 of about 25,145 (199)

Inevitable high-dose irradiation to lead of implantable cardioverter defibrillator in small cell lung cancer: a case report

Journal of Medical Case Reports, 2019
Background Radiotherapy has been shown to cause malfunction of implantable cardioverter-defibrillators, and there are few studies of implantable cardioverter-defibrillators and radiotherapy.
Jeong Won Lee, Ki Ho Seol
doaj   +1 more source

Reticular telangiectatic erythema: case report and literature review

Dermatology Practical & Conceptual, 2015
Background: Reticular telangiectatic erythema is a benign cutaneous reaction that may occur in patients who have received a subcutaneous implantable cardioverter-defibrillator.
Bryce D. Buetler, Philip R. Cohen
doaj   +1 more source

Subcutaneous Implantable Cardioverter-Defibrillator [PDF]

Circulation, 2014
For nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead.
Philip M, Chang, Rahul, Doshi, Leslie A, Saxon   +2 more
openaire   +2 more sources

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Among patients with an implantable cardioverter‐defibrillator, a high prevalence of atrial fibrillation (AF) is present. Identification of AF predictors in this patient group is of clinical importance to initiate appropriate preventive ...
Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Nikki van Pouderoijen, Judith Krabbenborg, Mark J. Mulder, Mischa T. Rijnierse, Pranav Bhagirath, Lourens F. H. J. Robbers, Albert C. van Rossum, Vokko P. van Halm, Marco J. W. Götte, Cornelis P. Allaart   +11 more
doaj   +1 more source

Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study

SAGE Open Medicine, 2016
Background: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients.
Jane MacIver, Alana Tibbles, Filio Billia, Heather Ross   +3 more
doaj   +1 more source

Implantable Cardioverter Defibrillator

Majalah Kardiologi Indonesia, 2013
Ide penggunaan Implantable Cardioverter Defibrillator (ICD) untuk pencegahan kematian jantung mendadak pertama kali dicetuskan oleh Dr. Michel Mirowski pada tahun 1970. Sejak itu ICD berkembang dari sebuah prototipe yang dicoba pada binatang menjadi alat
Dicky Armen Hanafy
doaj   +1 more source

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis.
Camilla H. B. Jespersen, Johanna Krøll, Priya Bhardwaj, Carl Johann Hansen, Jesper Svane, Bo G. Winkel, Christian Jøns, Peter Karl Jacobsen, Jens Haarbo, Jens Cosedis Nielsen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp‐Pedersen, Lars Køber, Jacob Tfelt‐Hansen, Peter E. Weeke   +16 more
doaj   +1 more source

New horizon for infection prevention technology and implantable device

Journal of Arrhythmia, 2016
There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades.
Yusuke Kondo, MD, PhD, Marehiko Ueda, MD, PhD, Yoshio Kobayashi, MD, PhD, Joerg O. Schwab, MD, PhD   +3 more
doaj   +1 more source

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiac sympathetic denervation (CSD) has been used as a bailout strategy for refractory ventricular tachycardia (VT). Risk of VT recurrence in patients with scar‐related monomorphic VT referred for CSD and the extent to which CSD can modify ...
Veronica Dusi, Jeffrey Gornbein, Duc H. Do, Julie M. Sorg, Houman Khakpour, Yuliya Krokhaleva, Olujimi A. Ajijola, Carlos Macias, Jason S. Bradfield, Eric Buch, Osamu A. Fujimura, Noel G. Boyle, Jane Yanagawa, Jay M. Lee, Kalyanam Shivkumar, Marmar Vaseghi   +15 more
doaj   +1 more source